| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.53 | 0.002 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.32 | 0.003 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.46 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.12 | 0.005 |